The prevalence and clinical relevance of p27 and cyclin E immunoreactivity in myelodysplastic syndromes.
Pruneri
Giancarlo
G
Fracchiolla
Nicola
N
Cortelezzi
Agostino
A
Ponzoni
Maurilio
M
Maisonneuve
Patrick
P
Lambertenghi-Deliliers
Giorgio
G
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000032:analysis; D019927:Cyclin E / Q000032:analysis*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000378:metabolism* / Q000401:mortality; D015995:Prevalence; D011379:Prognosis; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis*; D015996:Survival Rate
D015415:Biomarkers; D019927:Cyclin E; D018809:Proliferating Cell Nuclear Antigen; C413374:p27 antigen